Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - zoledronic acid, monohydrate - concentrate for solution for infusion - zoledronic acid monohydrate 4 mg - drugs for treatment of bone diseases

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - zoledronic acid - concentrate for solution for infusion - 4/5 milligram(s)/millilitre - bisphosphonates; zoledronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - methotrexate - concentrate for solution for infusion - 100 milligram(s)/millilitre - folic acid analogues; methotrexate

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - methotrexate - concentrate for solution for infusion - methotrexate 100 mg/ml - antineoplastic agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare polska sp. z o.o. - oxaliplatin - concentrate for solution for infusion - 5mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare polska sp. z o.o. - oxaliplatin - concentrate for solution for infusion - 5mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sodium acetate trihydrate 272 mg/ml equivalent to sodium acetate anhydrous 163 mg/ml - solution for injection - 1.64g/10ml - active: sodium acetate trihydrate 272 mg/ml equivalent to sodium acetate anhydrous 163 mg/ml excipient: water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - pertuzumab 420mg equivalent to 30 mg/ml - concentrate for infusion - 420 mg/14ml - active: pertuzumab 420mg equivalent to 30 mg/ml excipient: glacial acetic acid histidine polysorbate 20 sucrose water for injection - metastatic breast cancer perjeta is indicated in combination with trastuzumab and docetaxel for patients with her2-positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for their metastatic disease.